Cx611-0204 SEPCELL Study

Clinical trial NCT03158727 · COMPLETED

Trial details

NCT number: NCT03158727
Sponsor: Tigenix S.A.U.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Bacterial Pneumonia

Start date: 2017-01-30
Primary completion: 2020-07-07
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.